record

Ciganek LLC

Centreville, MD

Medication used in treatmentDirectory coverage. Read the methodology and limitations.

Facility contact

Care types: Substance use treatment, Detoxification Source
Care settings: Outpatient, Outpatient detoxification, Outpatient methadone/buprenorphine or naltrexone treatment Source
OUD medication support: Medication used in treatment Source
Opioid medications: Buprenorphine used in Treatment, Naltrexone used in Treatment Source
Opioid treatment responses: Buprenorphine detoxification, Buprenorphine maintenance, Prescribes buprenorphine, Prescribes naltrexone, Relapse prevention with naltrexone, Lofexidine or Clonidine detoxification, Maintenance service with medically supervised withdrawal after stabilization Source
Other pharmacotherapies: Acamprosate (Campral®), Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Clonidine Source
Detoxification services: Alcohol Detoxification, Benzodiazepines Detoxification, Opioids detoxification, Medication routinely used during detoxification Source
Treatment approaches: Telemedicine/telehealth therapy Source

Age groups: Young Adults, Adults, Seniors Source
Special programs: Adult women, Pregnant/postpartum women, Adult men, Seniors or older adults, Veterans, Active duty military, Members of military families, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring pain and substance use disorders Source
Co-occurring treatment reported: Yes Source
All oversight and accreditation responses: State substance use treatment agency, State mental health department, State department of health, SAMHSA certification for opioid treatment program (OTP) Source
Facility operation: Private for-profit organization Source
Directory field completeness: 100 / 100 Source

Research workflow

Unlock shortlist comparison, local notes, export, and complete directory context.